Growth Metrics

Dna X (SONM) Receivables - Other (2020 - 2025)

Historic Receivables - Other for Dna X (SONM) over the last 6 years, with Q3 2025 value amounting to $9.8 million.

  • Dna X's Receivables - Other rose 12769.55% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year increase of 12769.55%. This contributed to the annual value of $7.1 million for FY2024, which is 64079.08% up from last year.
  • Latest data reveals that Dna X reported Receivables - Other of $9.8 million as of Q3 2025, which was up 12769.55% from $7.0 million recorded in Q2 2025.
  • Dna X's 5-year Receivables - Other high stood at $9.8 million for Q3 2025, and its period low was $890000.0 during Q3 2022.
  • Its 5-year average for Receivables - Other is $3.6 million, with a median of $2.6 million in 2021.
  • In the last 5 years, Dna X's Receivables - Other plummeted by 7165.39% in 2022 and then soared by 64079.08% in 2024.
  • Dna X's Receivables - Other (Quarter) stood at $2.3 million in 2021, then rose by 0.62% to $2.3 million in 2022, then crashed by 57.65% to $961000.0 in 2023, then skyrocketed by 640.79% to $7.1 million in 2024, then skyrocketed by 38.24% to $9.8 million in 2025.
  • Its last three reported values are $9.8 million in Q3 2025, $7.0 million for Q2 2025, and $6.5 million during Q1 2025.